Clinical trial
Opioid Antagonism Enhances Marijuana's Effects in Heavy Marijuana Smokers
NCT00403117 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Opioid Antagonism Enhances Marijuana's Effects in Heavy Marijuana Smokers
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2006
- Completion date
- August 31, 2010
- Enrollment
- 49 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.